Home � Products & Services � Benchmarking Reports � Medical Affairs � Health Outcomes

Global Medical Affairs Resourcing Benchmark for HEOR Functions

Download FREE Excerpt

ID: POP-380

Features:

9 Info Graphics

16 Data Graphics

430+ Metrics

23 Narratives

Pages: 32

Published: 2024

Delivery Format: Shipped

License Options:
$4000 - 1 user
$12000 - Up to 5 users
$20000 - Up to 20 users

Buy Now

919-403-0251

Schedule a Meeting

STUDY OVERVIEW
BENCHMARK CLASS
STUDY SNAPSHOT
KEY FINDINGS
VIEW TOC AND LIST OF EXHIBITS

Strategic resource allocation within the Health Economics and Outcomes Research (HEOR) function is critical to ensure productivity and cost-effectiveness in support of high impact. A key consideration in resourcing the HEOR function is determining the types and degree of outsourcing. The decision to insource or outsource HEOR activities can redefine core capabilities, drastically affect costs, and strengthen support across therapeutic domains.

Best Practices, LLC conducted this benchmarking research to probe the intricacies of HEOR resourcing within mid-sized and large biopharma organizations. The report investigates productivity metrics, outsourcing benchmarks, spend patterns, and staffing dynamics - within outsourcing, insourcing and hybrid models. These insights will provide HEOR leadership with the knowledge to navigate complexities effectively, enhance productivity, and drive sustainable growth within HEOR functions (both it resides within Medical Affairs and in other parts of the organizations).

Video Brief:

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Consumer Products; Health Care; Clinical Research; Laboratories

Companies Profiled:
AbbVie; Acadia Pharmaceuticals; Agenus; Alexion Pharmaceuticals; Astellas; Domp�; Fidia Pharma USA Inc.; Gilead Sciences; Novartis; Novo Nordisk; Organon; Pfizer; Pixacore; Protagonist Therapeutics; Regeneron; Sanofi; Sobi; Teva Pharmaceuticals; United Therapeutics; UCB Pharma

Study Snapshot

This report offers tailored benchmarks and insights focused on the HEOR function. The data from this research is drawn by engaging 22 Medical leaders from 20 leading mid-cap and large biopharma organizations, with expertise encompassing HEOR, Medical Publications & Strategy. HEOR insights are meticulously distilled to ensure relevance and applicability within the scope of this research.

Key topics covered in this report include:

HEOR Outsourcing Trends
Scope of Support
Productivity and Outsourced Capabilities
HEOR Staffing Dynamics
Hybrid Resourcing Benefits

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

Outsourcing Is Ubiquitous Across Global HEOR: The majority of surveyed mid-cap and large companies predominantly outsource most activities, relying significantly on outsourcing for their operations.

Factors Driving Insourcing in HEOR: 63% of companies say it is “absolutely critical” to retain some degree of in-house HEOR expertise, and many believe insourced research yields higher quality work product.

Table of Contents

Sr. No.	Topic	Slide No.
I.	Executive Summary	Pg. 3-8
II.	HEOR Resourcing: Scope of Support & Alignment	Pg. 9-13
III.	Productivity & Capabilities of Outsourced vs. Insourced HEOR Models	Pg. 14-21
IV.	Staffing & Resourcing Trends	Pg. 22-31
V.	About Best Practices, LLC	Pg. 32

List of Charts & Exhibits

I. Executive Summary

Research methodology and scope overview
Global HEOR benchmark study partners
Overarching findings for HEOR resourcing and service delivery
HEOR industry benchmarks
Study summary for HEOR leadership resourcing decisions

II. HEOR Resourcing: Scope of Support & Alignment

HEOR group alignment
HEOR support across the product lifecycle
Scope of HEOR support and total annual HEOR spend

III. Productivity & Capabilities of Outsourced vs. Insourced HEOR Models

Average annual volume of HEOR activities
Interview narratives around the use of hybrid models
Extent of outsourcing in HEOR activities
Outsourcing x Productivity Matrix: RWE/Claims/HCRU/Epidemiology/Costing studies/
External control arms development
Outsourcing x Productivity Matrix: Systemic/Targeted literature reviews
Outsourcing x Productivity Matrix: AMCP/Global value dossiers
Outsourcing x Productivity Matrix: Budget impact models

IV. Staffing & Resourcing Trends

Number of FTEs (full-time equivalent employees) and CWs (contract workers) dedicated to each HEOR role
Staffing levels per brand
Benefits of an outsourced HEOR model
Benefits of an in-house HEOR model
Quantifying the benefits of HEOR resourcing model
Key HEOR trends
Lessons learned relating to the outsourcing and insourcing of HEOR capabilities
Geographical responsibility of benchmark partners

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B9B48B3104F4A73A00258B1D0044E7D2
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/global-medical-affairs-resourcing-benchmark-for-heor-functions
18
19
20172.71.254.202
21
22
23527255.sherryhk.tech
24/bestp/domrep.nsf
25BMR